期刊
BIOCHEMICAL SOCIETY TRANSACTIONS
卷 40, 期 -, 页码 1134-1139出版社
PORTLAND PRESS LTD
DOI: 10.1042/BST20120119
关键词
cytokine; immune system; leucine-rich repeat kinase 2 (LRRK2); Parkinson's disease; receptor-interacting protein kinase (RIPK); Toll-like receptor (TLR)
资金
- National Health and Medical Research Council (NHMRC)
Missense mutations in LRRK2 (leucine-rich repeat kinase 2) contribute significantly to autosomal dominant PD (Parkinson's disease). Genome-wide association studies have suggested further that mutations in LRRK2 comprise a risk factor for sporadic PD. How LRRK2 contributes to PD, however, is largely unknown. Recent work has shown that LRRK2 is highly expressed in tissue and circulating immune cells and is suggestive of a potential role for LRRK2 in innate immunity. These studies and their potential implications for PD are discussed in the present paper.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据